A new anemia treatment drug for people going through kidney dialysis has been officially recalled. As reported by The New York Times, Affymax and Takeda Pharmaceutical have recalled all lots of Omontys, or peginesatide, because of the severe allergic reactions it can cause.
The Food and Drug Administration (FDA) says that there have been 19 reports of anaphylaxis, a very serious allergic reaction. Three of those victims died and the remaining 16 required prompt medical intervention or hospitalization. The companies say that two out of every 1,000 patients had a hypersensitivity reaction.
When a person has a low red blood cell count, it is called anemia. This means that the blood is not carrying enough oxygen to tissues and organs throughout their body. Anemia is common in people who are suffering from kidney disease because healthy kidneys produce the hormone erythropoietin, which stimulates bone marrow to produce the proper number of red blood cells to carry oxygen.
If you are taking Omontys, it is important that you speak to your doctor right away. You should know, however, that all of the reported reactions occurred in patients within 30 minutes of receiving their first dose and that no patients have suffered symptoms from additional doses.
If you or a loved one has suffered unexpected side effects after taking a prescription or over-the-counter drug, there may be financial compensation available for your losses. It is important to discuss your case with a skilled product liability attorney who will help you hold the at-fault manufacturer of the defective drug accountable.
The experienced Georgia defective drug injury attorneys at The Law Offices of Wayne Grant, P.C., offer free consultations at (404) 995-3955 to anyone who has suffered a loss because of a defective or recalled drug. We help patients seek compensation for damages such as medical expenses, lost wages, cost of hospitalization, and other related damages. Please contact us today to find out how we can help you.